​

Paysign, Inc.

NasdaqCM:PAYS Stock Report

Market Cap: US$425.6m

Paysign (PAYS) Stock Overview

Provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. More details

PAYS fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Rewards

Earnings are forecast to grow 28.7% per year

Risk Analysis

High level of non-cash earnings

Volatile share price over the past 3 months compared to the US market

Profit margins (9.6%) are lower than last year (13.8%)


PAYS Community Fair Values

Create Narrative

See what 27 others think this stock is worth. Follow their fair value or set your own to get alerts.

PAYS logo
Paysign
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts

Digital Payments And Healthcare Trends Will Drive Expansion

Key Takeaways New program wins and strengthening digital capabilities position Paysign for rapid revenue and margin growth, with pharma affordability poised to surpass legacy segments. Operational scale, automation, and compliance infrastructure create durable competitive advantages, enabling profitable expansion and increased revenue per client as digital adoption accelerates.
View narrative
US$9.50
FV
17.4% undervalued intrinsic discount
24.96%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
about 7 hours ago author updated this narrative
PAYS logo
Paysign
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts

Patient Affordability And SaaS Entry Will Promise Success With Risks

Key Takeaways Acquisition of Gamma Innovation LLC expands Paysign into high-margin SaaS market, boosting potential revenue through integrated plasma and pharmaceutical solutions. Strong patient affordability segment growth, debt-free status, and cash reserves position Paysign well for future opportunities and market stability.
View narrative
US$6.54
FV
20.0% overvalued intrinsic discount
15.65%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
5 days ago author updated this narrative
PAYS logo
Paysign
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts

Plasma Decline And Fintech Risks Will Test Stability, Affordability Helps

Key Takeaways Overdependence on plasma and pharma reimbursement segments, combined with customer concentration, creates significant vulnerability to revenue and margin disruption. Rising compliance costs, competition from fintech innovation, and declining demand for prepaid cards threaten long-term growth and profitability.
View narrative
US$7.00
FV
12.1% overvalued intrinsic discount
24.63%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
12 days ago author updated this narrative
View Paysign Community

Paysign, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Paysign
Historical stock prices
Current Share PriceUS$7.85
52 Week HighUS$8.57
52 Week LowUS$1.80
Beta0.75
1 Month Change61.52%
3 Month Change265.12%
1 Year Change81.29%
3 Year Change356.40%
5 Year Change-16.93%
Change since IPO1,644.44%

Recent News & Updates

Recent updates

Paysign, Inc.'s (NASDAQ:PAYS) 28% Price Boost Is Out Of Tune With Earnings

May 06
Paysign, Inc.'s (NASDAQ:PAYS) 28% Price Boost Is Out Of Tune With Earnings

Paysign, Inc.'s (NASDAQ:PAYS) Share Price Not Quite Adding Up

Mar 04
Paysign, Inc.'s (NASDAQ:PAYS) Share Price Not Quite Adding Up

Here's Why Paysign (NASDAQ:PAYS) Has Caught The Eye Of Investors

Dec 27
Here's Why Paysign (NASDAQ:PAYS) Has Caught The Eye Of Investors

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Nov 20
author-image

Rapid Growth In Patient Affordability Market Fuels Optimism Despite Looming Margin Pressures

The expansion into the patient affordability segment and significant client growth, like AstraZeneca, indicates a promising area for revenue and earnings increases.

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

Sep 07
Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 02
Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Paysign: Expect Rapid Growth In Its Pharma Business

Jun 30

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Apr 26
Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Here's Why We Think PaySign (NASDAQ:PAYS) Is Well Worth Watching

Mar 29
Here's Why We Think PaySign (NASDAQ:PAYS) Is Well Worth Watching

Revenues Tell The Story For PaySign, Inc. (NASDAQ:PAYS)

Jan 25
Revenues Tell The Story For PaySign, Inc. (NASDAQ:PAYS)

The Recovery At PaySign Has Legs

Aug 30

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Aug 13
Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

Jun 14
Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

May 16
At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

PaySign: A 'Backdoor' $2 Stagflation Play

Mar 29

Paysign: My Top Rebound Pick For 2022

Dec 28

Paysign: The Plasma Toll Booth

Sep 23

PaySign's Post-Pandemic Payoff

Sep 07

Shareholder Returns

PAYSUS Diversified FinancialUS Market
7D-5.0%-2.5%0.1%
1Y81.3%16.8%11.4%

Return vs Industry: PAYS exceeded the US Diversified Financial industry which returned 16.8% over the past year.

Return vs Market: PAYS exceeded the US Market which returned 11.4% over the past year.

Price Volatility

Is PAYS's price volatile compared to industry and market?
PAYS volatility
PAYS Average Weekly Movement11.6%
Diversified Financial Industry Average Movement5.5%
Market Average Movement6.4%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market3.2%

Stable Share Price: PAYS's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: PAYS's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2001173Mark Newcomerwww.paysign.com

Paysign, Inc. provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. It offers solutions for corporate rewards, prepaid gift cards, general-purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card. The company also operates a customer service center; and offers a communication suite, including a kiosk, mobile app, two-way SMS, text alerts, and cardholder web portal.

Paysign, Inc. Fundamentals Summary

How do Paysign's earnings and revenue compare to its market cap?
PAYS fundamental statistics
Market capUS$425.61m
Earnings (TTM)US$6.09m
Revenue (TTM)US$63.79m
69.9x
P/E Ratio
6.7x
P/S Ratio

Is PAYS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PAYS income statement (TTM)
RevenueUS$63.79m
Cost of RevenueUS$26.84m
Gross ProfitUS$36.95m
Other ExpensesUS$30.86m
EarningsUS$6.09m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Aug 05, 2025

Earnings per share (EPS)0.11
Gross Margin57.92%
Net Profit Margin9.55%
Debt/Equity Ratio0%

How did PAYS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/14 08:37
End of Day Share Price 2025/07/11 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Paysign, Inc. is covered by 6 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gary PrestopinoBarrington Research Associates, Inc.
Austin MoldowCanaccord Genuity
Peter HeckmannD.A. Davidson & Co.